BLSM
BlossomHill Therapeutics, Inc.
19.80$
-3.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of BlossomHill Therapeutics, Inc. (BLSM) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/18/2026 | Current report (8-K) | BlossomHill Therapeutics, Inc. (BLSM): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 09/15/2026 | Current report (8-K) | BlossomHill Therapeutics, Inc. (BLSM): Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 08/18/2026 | Ownership disclosure | Form SC 13D filed with the SEC | View document ↗ |
| 08/17/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 08/14/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 08/13/2026 | Ownership disclosure | Form SC 13D filed with the SEC | View document ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.